PROFILES - Connect with RTRN Researchers

Michael J Gonzalez
Title Dr.
Faculty Rank Professor
Degree DSc, NMD, PhD
Institution University of Puerto Rico
Department Public Health
Clusters Cancer
University of Puerto Rico
Medical Sciences Campus
School of Public Health
Dept Human Development, Nutrition Program
City San Juan
State PR
Postal Code 00938-5067
Telephone 787758-2525 e 1405
Fax 787 759-6719
QR Barcode

Other Positions icon

Title Adjunct Professor
Institution University of Western States
Department Human Nutrition and Functional Medicine
Division Functional Medicine
Title Adjunct Professor
Institution EDP University
Department Naturopathic Sciences
Division Biochemistry and Nutrition

Narrative icon

  Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the University of Western States. He earned a Bachelor Degree in Biology and Chemistry (Catholic University), a Masters in Cellular Biology and Biophysics (Nova University), and another Masters in Nutrition and Public Health (University of PR Med Sciences Campus). He has a Doctorate in Nutritional Medicine (John F. Kennedy University). He also has a Doctorate in Health Sciences (Lafayette University), and another Doctorate in Nutritional Biochemistry and Cancer Biology (Michigan State University). He completed a Post-Doctoral Fellowship in Geriatrics at the School of Medicine, University of Puerto Rico. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 150 scientific publications. He has serve as a member on several scientific journal Editorial Boards, such as Biomedicina, the Journal of Orthomolecular Medicine, and Alternative Medicine Reviews. He has served as consultant for several companies, he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He has also been a consultant for The Center for the Improvement of Human Functioning (now Riordan Clinic), in Wichita, Kansas. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. Gonzalez also serves as a nutrition consultant to the Puerto Rican Basketball National Team and is part of the Medical Commission of the Puerto Rican Basketball Federation. He is in a part time clinical practice with Dr. Miguel J Berdiel in Ponce, PR. In December 2013,Dr Gonzalez was exalted as Distinguished Ponceño in Medicine.

Doctor González and Dr. Jorge Miranda-Massari, founders of InBioMed, are leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. They have brought many new concepts into the scientific field, such as the Bioenergetic theory of carcinogenesis, the systemic saturation phenomenon of intravenous vitamin C, the metabolic correction concept for disease treatment and prevention. Currently they are finishing a book on Vitamin C and Cancer for Springer-Larger.

Book: Doctors Gonzalez, Miranda-Massari and Saul’s book “I Have Cancer What Should I do: The Orthomolecular Guide to Cancer Management” provides evidence based recommendations for an integrative approach for those dealing with cancer and seeking to improve quality of life and survival.

Publications icon

  Check NIH Public Access Policy Compliance

Please wait
1. Horga A, Tomaselli PJ, Gonzalez MA, Laurà M, Muntoni F, Manzur AY, Hanna MG, Blake JC, Houlden H, Züchner S, Reilly MM. SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome. Neurology. 2016 Oct 11; 87(15):1607-1612.
2. Vaddula BR, Tantak MP, Sadana R, Gonzalez MA, Kumar D. One-pot synthesis and in-vitro anticancer evaluation of 5-(2'-indolyl)thiazoles. Sci Rep. 2016 Mar 29; 6:23401.
3. Hickey S, Schuitemaker G, Yanagisawa A, Noriega L, González MJ, Miranda-Massari JR, Chibelushi C, Downing D. Archaic RDA Methodology for Vitamin C. Crit Rev Food Sci Nutr. 2015 Oct 29.
4. Goodson WH, Lowe L, Carpenter DO, Gilbertson M, Manaf Ali A, Lopez de Cerain Salsamendi A, Lasfar A, Carnero A, Azqueta A, Amedei A, Charles AK, Collins AR, Ward A, Salzberg AC, Colacci A, Olsen AK, Berg A, Barclay BJ, Zhou BP, Blanco-Aparicio C, Baglole CJ, Dong C, Mondello C, Hsu CW, Naus CC, Yedjou C, Curran CS, Laird DW, Koch DC, Carlin DJ, Felsher DW, Roy D, Brown DG, Ratovitski E, Ryan EP, Corsini E, Rojas E, Moon EY, Laconi E, Marongiu F, Al-Mulla F, Chiaradonna F, Darroudi F, Martin FL, Van Schooten FJ, Goldberg GS, Wagemaker G, Nangami GN, Calaf GM, Williams G, Wolf GT, Koppen G, Brunborg G, Lyerly HK, Krishnan H, Ab Hamid H, Yasaei H, Sone H, Kondoh H, Salem HK, Hsu HY, Park HH, Koturbash I, Miousse IR, Scovassi AI, Klaunig JE, Vondrácek J, Raju J, Roman J, Wise JP, Whitfield JR, Woodrick J, Christopher JA, Ochieng J, Martinez-Leal JF, Weisz J, Kravchenko J, Sun J, Prudhomme KR, Narayanan KB, Cohen-Solal KA, Moorwood K, Gonzalez L, Soucek L, Jian L, D'Abronzo LS, Lin LT, Li L, Gulliver L, McCawley LJ, Memeo L, Vermeulen L, Leyns L, Zhang L, Valverde M, Khatami M, Romano MF, Chapellier M, Williams MA, Wade M, Manjili MH, Lleonart ME, Xia M, Gonzalez MJ, Karamouzis MV, Kirsch-Volders M, Vaccari M, Kuemmerle NB, Singh N, Cruickshanks N, Kleinstreuer N, van Larebeke N, Ahmed N, Ogunkua O, Krishnakumar PK, Vadgama P, Marignani PA, Ghosh PM, Ostrosky-Wegman P, Thompson PA, Dent P, Heneberg P, Darbre P, Sing Leung P, Nangia-Makker P, Cheng QS, Robey RB, Al-Temaimi R, Roy R, Andrade-Vieira R, Sinha RK, Mehta R, Vento R, Di Fiore R, Ponce-Cusi R, Dornetshuber-Fleiss R, Nahta R, Castellino RC, Palorini R, Abd Hamid R, Langie SA, Eltom SE, Brooks SA, Ryeom S, Wise SS, Bay SN, Harris SA, Papagerakis S, Romano S, Pavanello S, Eriksson S, Forte S, Casey SC, Luanpitpong S, Lee TJ, Otsuki T, Chen T, Massfelder T, Sanderson T, Guarnieri T, Hultman T, Dormoy V, Odero-Marah V, Sabbisetti V, Maguer-Satta V, Rathmell WK, Engström W, Decker WK, Bisson WH, Rojanasakul Y, Luqmani Y, Chen Z, Hu Z. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead. Carcinogenesis. 2015 Jun; 36 Suppl 1:S254-96.
5. Miranda-Massari JR, Gonzalez MJ, Fernando AS, Cidre C, Paz IM, Charvel J, Martínez V, Duconge J, Aponte A, Ricart CM. Metabolic Correction as a tool to improve diabetes type 2 management. Bol Asoc Med P R. 2015 Apr-Jun; 107(2):54-9.
6. Miranda-Massari JR, González MJ, Rodriguez-Gomez JR, Duconge J, Allende-Vigo MZ, Jiménez Ramirez FJ, Cintrón K, Ricart C, Zaragoza-Urdaz R, Berdiel MJ, Vázquez A. [Metabolic correction: a biochemical option against diseases]. Bol Asoc Med P R. 2015 Apr-Jun; 107(2):60-6.
7. González MJ, Miranda-Massari JR, Duconge J, Allende-Vigo MZ, Jiménez-Ramírez FJ, Cintrón K, Rodríguez-Gómez JR, Rosario G, Ricart C, Santiago-Cornier JA, Zaragoza-Urdaz R, Vázquez A, Hickey S, Jabbar-Berdiel M, Riordan N, Ichim T, Santiago O, Alvarado G, Vora P. Metabolic correction: a functional biochemical mechanism against disease--Part 1: concept and historical background. P R Health Sci J. 2015 Mar; 34(1):3-8.
8. Miranda-Massari JR, González MJ, Duconge J, Allende-Vigo MZ, Jiménez-Ramírez FJ, Hickey S, Vázquez A, Berdiel MJ, Cintrón K, Rodríguez-Gómez JR. Metabolic correction: a functional biochemical mechanism against disease--Part 2: mechanisms and benefits. P R Health Sci J. 2015 Mar; 34(1):9-13.
9. Griffin LB, Sakaguchi R, McGuigan D, Gonzalez MA, Searby C, Züchner S, Hou YM, Antonellis A. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum Mutat. 2014 Nov; 35(11):1363-71.
10. Gonzalez MJ, Miranda-Massari JR. Diet and stress. Psychiatr Clin North Am. 2014 Dec; 37(4):579-89.
11. Bonifert T, Karle KN, Tonagel F, Batra M, Wilhelm C, Theurer Y, Schoenfeld C, Kluba T, Kamenisch Y, Carelli V, Wolf J, Gonzalez MA, Speziani F, Schüle R, Züchner S, Schöls L, Wissinger B, Synofzik M. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Brain. 2014 Aug; 137(Pt 8):2164-77.
12. Caballero Oteyza A, Battaloglu E, Ocek L, Lindig T, Reichbauer J, Rebelo AP, Gonzalez MA, Zorlu Y, Ozes B, Timmann D, Bender B, Woehlke G, Züchner S, Schöls L, Schüle R. Motor protein mutations cause a new form of hereditary spastic paraplegia. Neurology. 2014 Jun 03; 82(22):2007-16.
13. Foley MH, Forcier T, McAndrew E, Gonzalez M, Chen H, Juelg B, Walker BD, Irvine DJ. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function. PLoS One. 2014; 9(2):e87873.
14. Dolzhanskaya N, Gonzalez MA, Sperziani F, Stefl S, Messing J, Wen GY, Alexov E, Zuchner S, Velinov M. A novel p.Leu(381)Phe mutation in presenilin 1 is associated with very early onset and unusually fast progressing dementia as well as lysosomal inclusions typically seen in Kufs disease. J Alzheimers Dis. 2014; 39(1):23-7.
15. Gonzalez MJ, Miranda-Massari JR, Berdiel MJ, Duconge J, Rodríguez-López JL, Hunninghake R, Cobas-Rosario VJ. High Dose Intraveneous Vitamin C and Chikungunya Fever: A Case Report. J Orthomol Med. 2014; 29(4):154-156.
16. Foley AR, Menezes MP, Pandraud A, Gonzalez MA, Al-Odaib A, Abrams AJ, Sugano K, Yonezawa A, Manzur AY, Burns J, Hughes I, McCullagh BG, Jungbluth H, Lim MJ, Lin JP, Megarbane A, Urtizberea JA, Shah AH, Antony J, Webster R, Broomfield A, Ng J, Mathew AA, O'Byrne JJ, Forman E, Scoto M, Prasad M, O'Brien K, Olpin S, Oppenheim M, Hargreaves I, Land JM, Wang MX, Carpenter K, Horvath R, Straub V, Lek M, Gold W, Farrell MO, Brandner S, Phadke R, Matsubara K, McGarvey ML, Scherer SS, Baxter PS, King MD, Clayton P, Rahman S, Reilly MM, Ouvrier RA, Christodoulou J, Züchner S, Muntoni F, Houlden H. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain. 2014 Jan; 137(Pt 1):44-56.
17. Mateo J, Ong M, Tan DS, Gonzalez MA, de Bono JS. Appraising iniparib, the PARP inhibitor that never was--what must we learn? Nat Rev Clin Oncol. 2013 Dec; 10(12):688-96.
18. González AM, Cruz SY, Ríos JL, Pagán I, Fabián C, Betancourt J, Rivera-Soto WT, González MJ, Palacios C. Alcohol consumption and smoking and their associations with socio-demographic characteristics, dietary patterns, and perceived academic stress in Puerto Rican college students. P R Health Sci J. 2013 Jun; 32(2):82-8.
19. Betancourt J, Ríos JL, Pagán I, Fabián C, González AM, Cruz SY, González MJ, Rivera WT, Palacios C. Non-medical use of prescription drugs and its association with socio-demographic characteristics, dietary pattern, and perceived academic load and stress in college students in Puerto Rico. P R Health Sci J. 2013 Jun; 32(2):89-94.
20. Ríos JL, Betancourt J, Pagán I, Fabián C, Cruz SY, González AM, González MJ, Rivera-Soto WT, Palacios C. Caffeinated-beverage consumption and its association with socio-demographic characteristics and self-perceived academic stress in first and second year students at the University of Puerto Rico Medical Sciences Campus (UPR-MSC). P R Health Sci J. 2013 Jun; 32(2):95-100.
21. Oates EC, Rossor AM, Hafezparast M, Gonzalez M, Speziani F, MacArthur DG, Lek M, Cottenie E, Scoto M, Foley AR, Hurles M, Houlden H, Greensmith L, Auer-Grumbach M, Pieber TR, Strom TM, Schule R, Herrmann DN, Sowden JE, Acsadi G, Menezes MP, Clarke NF, Züchner S. Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet. 2013 Jun 06; 92(6):965-73.
22. Fabián C, Pagán I, Ríos JL, Betancourt J, Cruz SY, González AM, Palacios C, González MJ, Rivera-Soto WT. Dietary patterns and their association with sociodemographic characteristics and perceived academic stress of college students in Puerto Rico. P R Health Sci J. 2013 Mar; 32(1):36-43.
23. Cruz SY, Fabián C, Pagán I, Ríos JL, González AM, Betancourt J, González MJ, Rivera-Soto WT, Palacios C. Physical activity and its associations with sociodemographic characteristics, dietary patterns, and perceived academic stress in students attending college in Puerto Rico. P R Health Sci J. 2013 Mar; 32(1):44-50.
24. Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T, Quintero-Del-Rio AI, Ortiz N. The bio-energetic theory of carcinogenesis. Med Hypotheses. 2012 Oct; 79(4):433-9.
25. Gonzalez MJ, Miranda Massari JR, Duconge J, Riordan NH, Ichim T. Schedule Dependence in Cancer Therapy: Intravenous Vitamin C and the Systemic Saturation Hypothesis. J Orthomol Med. 2012 Jan 01; 27(1):9-12.
26. Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom control. Curr Clin Pharmacol. 2011 Nov; 6(4):260-73.
27. Ichim TE, Minev B, Braciak T, Luna B, Hunninghake R, Mikirova NA, Jackson JA, Gonzalez MJ, Miranda-Massari JR, Alexandrescu DT, Dasanu CA, Bogin V, Ancans J, Stevens RB, Markosian B, Koropatnick J, Chen CS, Riordan NH. Intravenous ascorbic acid to prevent and treat cancer-associated sepsis? J Transl Med. 2011 Mar 04; 9:25.
28. González MJ, Miranda-Massari JR, Duconge J. Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later: comment on the article by Cabanillas. P R Health Sci J. 2010 Dec; 29(4):410-1; author reply 411-2.
29. González MJ, Rosario-Pérez G, Guzmán AM, Miranda-Massari JR, Duconge J, Lavergne J, Fernandez N, Ortiz N, Quintero A, Mikirova N, Riordan NH, Ricart CM. Mitochondria, Energy and Cancer: The Relationship with Ascorbic Acid. J Orthomol Med. 2010; 25(1):29-38.
30. Meyer DE, Curran MA, Gonzalez MA. An examination of existing data for the industrial manufacture and use of nanocomponents and their role in the life cycle impact of nanoproducts. Environ Sci Technol. 2009 Mar 01; 43(5):1256-63.
31. Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W, Riordan NH. Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J. 2008 Mar; 27(1):7-19.
32. Duconge J, Miranda-Massari JR, González MJ, Taylor PR, Riordan HD, Riordan NH, Casciari JJ, Alliston K. Vitamin C pharmacokinetics after continuous infusion in a patient with prostate cancer. Ann Pharmacother. 2007 Jun; 41(6):1082-3.
33. Gonzalez MJ, Miranda-Massari JR. Advances in vitamin C research. Integr Cancer Ther. 2006 Mar; 5(1):7-8.
34. González MJ, Herrera FL, Miranda-Massari JM, Guzmán AM, Riordan NH, Ricart CM. Tumor growth parameters of in-vivo human breast carcinoma: a proposed mathematical model for tumor growth kinetics. P R Health Sci J. 2006 Mar; 25(1):71-3.
35. Riordan HD, Casciari JJ, González MJ, Riordan NH, Miranda-Massari JR, Taylor P, Jackson JA. A pilot clinical study of continuous intravenous ascorbate in terminal cancer patients. P R Health Sci J. 2005 Dec; 24(4):269-76.
36. Casciari JJ, Riordan HD, Miranda-Massari JR, Gonzalez MJ. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs. P R Health Sci J. 2005 Jun; 24(2):145-50.
37. González MJ, Miranda-Massari JR, Mora EM, Guzmán A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Román-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005 Mar; 4(1):32-44.
38. Gonzalez MA, Tachibana KE, Laskey RA, Coleman N. Control of DNA replication and its potential clinical exploitation. Nat Rev Cancer. 2005 02; 5(2):135-41.
39. Gonzalez MA, Tachibana KE, Chin SF, Callagy G, Madine MA, Vowler SL, Pinder SE, Laskey RA, Coleman N. Geminin predicts adverse clinical outcome in breast cancer by reflecting cell-cycle progression. J Pathol. 2004 Oct; 204(2):121-30.
40. Meng X, Riordan NH, Riordan HD, Mikirova N, Jackson J, González MJ, Miranda-Massari JR, Mora E, Trinidad Castillo W. Cell membrane fatty acid composition differs between normal and malignant cell lines. P R Health Sci J. 2004 Jun; 23(2):103-6.
41. Mikirova N, Riordan HD, Jackson JA, Wong K, Miranda-Massari JR, Gonzalez MJ. Erythrocyte membrane fatty acid composition in cancer patients. P R Health Sci J. 2004 Jun; 23(2):107-13.
42. Riordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A. Intravenous vitamin C as a chemotherapy agent: a report on clinical cases. P R Health Sci J. 2004 Jun; 23(2):115-8.
43. González MJ, Ricart CM, Miranda-Massari J. A vitamin, mineral, herb dietary supplement effect on blood glucose in uncontrolled type II diabetic subjects. P R Health Sci J. 2004 Jun; 23(2):119-20.
44. González MJ, Miranda-Massari JR, Ricart CM. Effect of a dietary supplement combination on weight management, adipose tissue, cholesterol and triglycerides in obese subjects. P R Health Sci J. 2004 Jun; 23(2):121-4.
45. Gonzalez MA, Pinder SE, Callagy G, Vowler SL, Morris LS, Bird K, Bell JA, Laskey RA, Coleman N. Minichromosome maintenance protein 2 is a strong independent prognostic marker in breast cancer. J Clin Oncol. 2003 Dec 01; 21(23):4306-13.
46. Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, González MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. Intravenous ascorbic acid: protocol for its application and use. P R Health Sci J. 2003 Sep; 22(3):287-90.
47. González MJ, Mora EM, Miranda-Massari JR, Matta J, Riordan HD, Riordan NH. Inhibition of human breast carcinoma cell proliferation by ascorbate and copper. P R Health Sci J. 2002 Mar; 21(1):21-3.
48. González MJ, Miranda-Massari JR, Mora EM, Jiménez IZ, Matos MI, Riordan HD, Casciari JJ, Riordan NH, Rodríguez M, Guzmán A. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity. P R Health Sci J. 2002 Mar; 21(1):39-41.
49. González MJ, Miranda-Massari JR, Mora EM, Cruzado NA, Jiménez I, Rosa M, Matos Vera MI, Santiago C, Román-Eyxarch MI, Rodríguez JR, Pérez Cortés C, Riordan NH, Riordan HD, Ricart CM. Integrative medicine: a paradigm shift in medical education and practice. P R Health Sci J. 2000 Dec; 19(4):389-92.
50. González L, Nazario CM, González MJ. Nutrition-related problems of pediatric patients with neuromuscular disorders. P R Health Sci J. 2000 Mar; 19(1):35-8.
51. Santiago E, González MJ, Matos MI, Pérez CM. Association between dietary fat and breast cancer in Puerto Rican postmenopausal women attending a breast cancer clinic. P R Health Sci J. 1998 Sep; 17(3):235-41.
52. Santiago E, González MJ, Matos MI, Pérez CM. Dietary fat and breast cancer: a brief update on current knowledge. P R Health Sci J. 1998 Sep; 17(3):273-9.
53. González MJ, Schmitz KJ, Matos MI, López D, Rodríguez JR, Gorrín JJ. Folate supplementation and neural tube defects: a review of a public health issue. P R Health Sci J. 1997 Dec; 16(4):387-93.
54. González MJ, Nazario CM. The effect of ascorbic acid on human T cells. P R Health Sci J. 1996 Dec; 15(4):309-10.
55. González MJ, Riordan NH. The paradoxical role of lipid peroxidation on carcinogenesis and tumor growth: a commentary. Med Hypotheses. 1996 Jun; 46(6):503-4.
56. Gonzalez MJ. Fish oil, lipid peroxidation and mammary tumor growth. J Am Coll Nutr. 1995 Aug; 14(4):325-35.
57. Petersmark K, Rodríguez JR, Matos MI, González MJ. Regional differences in fat cell lipolytic mechanisms: a critical review. P R Health Sci J. 1995 Mar; 14(1):11-6.
58. Gonzàlez MJ, Herrera FL. Cell loss and tumor growth revisited. Med Hypotheses. 1994 Jan; 42(1):39-42.
59. Gonzalez MJ, Schemmel RA, Dugan L, Gray JI, Welsch CW. Dietary fish oil inhibits human breast carcinoma growth: a function of increased lipid peroxidation. Lipids. 1993 Sep; 28(9):827-32.
60. Gonzalez MJ, Gray JI, Schemmel RA, Dugan L, Welsch CW. Lipid peroxidation products are elevated in fish oil diets even in the presence of added antioxidants. J Nutr. 1992 Nov; 122(11):2190-5.
61. Gonzalez MJ. Lipid peroxidation and tumor growth: an inverse relationship. Med Hypotheses. 1992 Jun; 38(2):106-10.
62. Gonzalez MJ, Schemmel RA, Gray JI, Dugan L, Sheffield LG, Welsch CW. Effect of dietary fat on growth of MCF-7 and MDA-MB231 human breast carcinomas in athymic nude mice: relationship between carcinoma growth and lipid peroxidation product levels. Carcinogenesis. 1991 Jul; 12(7):1231-5.
63. González MJ, Rodríguez JR. Fat and breast cancer: a mini-review of experimental data on rodents. Bol Asoc Med P R. 1991 Jun; 83(6):264-6.
64. Gonzalez MJ. Serum concentrations and cellular uptake of vitamin E. Med Hypotheses. 1990 Jun; 32(2):107-10.

Research Resources icon

Funding Opportunities icon

Browse active NIH & NSF funding opportunities, requests for applications (RFAs), and program announcements (PAs)

Publications Timeline

Top MeSH Keywords

Tree Map of Keyword Semantic Groups (Categories)

Left-click a node to move down the tree, right-click the graph to move back up the tree

Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
Last Name
Ascorbic Acid
Stress, Psychological
Breast Neoplasms
See all (350) keywords
See all (5) people See all (60) people Search for (3) people

RTRN Collaboration and Professional Networking Feedback